Remedy Place, the world’s first Social Wellness Club®, is expanding its impact beyond the four walls of its US brick-and-mortar locations with the launch of the NAD+ Smart Pen, a next-generation injectable designed to make clinical-grade NAD+ accessible at home. Developed in exclusive partnership with UK-based NADclinic, the leading clinic that first pioneered the technology, the pen contains 1,000 milligrams of high-purity NAD+, a naturally occurring coenzyme involved in cellular energy metabolism, with exclusive U.S. distribution rights held by Remedy Place.
Manufactured in a GMP-compliant pharmaceutical facility and supported by independent batch testing, the NAD+ Smart Pen is built on five decades of dedicated research and development. Created by a specialized pharmaceutical team with a singular focus on NAD+ purity and bioavailability, it offers unmatched quality and efficacy. Each formulation boasts a 24-month validated stability, and every NADSQx Smart Pen is accompanied by a Certificate of Analysis from an NHS/UKAS-accredited laboratory, ensuring full transparency and trust in every dose.
“After delivering tens of thousands of NAD+ IVs and injections at Remedy Place since 2019, we’ve seen meaningful demand for solutions that maintain integrity while offering greater convenience,” said Dr. Jonathan Leary, Founder and CEO of Remedy Place. “Our partnership with NADclinic allows us to introduce a precision-dosed, pharmaceutical-grade NAD+ format designed to uphold the standards our community expects.”
“This is a milestone collaboration for us,” said Iain De Havilland, CEO of NADclinic. “Remedy Place shares our commitment to quality, transparency, and responsible expansion. We are pleased to support their U.S. launch with a formulation developed to rigorous pharmaceutical standards.”
Equally important is what the formulation does not include. The NAD+ Smart Pen contains no stabilizers, fillers, or synthetic additives, preserving the integrity of the molecule and ensuring uncompromised performance. By eliminating unnecessary excipients, the formulation remains clean, concentrated, and aligned with pharmaceutical-grade principles rather than consumer-grade supplementation standards. Every detail, from sourcing to batch testing, has been designed to prioritize potency, precision, and reliability.
This collaboration introduces the “Gold Standard” NAD+ formulation into the most advanced smart pen delivery system available, elevating precision, accessibility, and performance in one seamless solution. Remedy Place holds exclusive U.S. distribution rights. The NAD+ Smart Pen will be available via remedyplace.naddirect.com as well as at Remedy Place’s New York City, Boston, and Los Angeles locations for $500 per pen, with the option to ship to any location within 48 hours.
For more information, visit remedyplace.naddirect.com.
Remedy Place is the world’s first Social Wellness Club, redefining how people care for themselves and connect with others. Founded by Dr. Jonathan Leary and in development since 2012, the concept was created to make healthy living social rather than isolating. Blending evidence-informed wellness technologies with elevated hospitality, Remedy Place offers experiences including private sauna suites, ice baths, breathwork, IV therapy, NAD+, hyperbaric sessions, acupuncture, chiropractic care, and functional medicine services across its U.S. locations.
About NADclinic
Founded in the United Kingdom, NADclinic specializes in NAD+ therapies developed with a focus on pharmaceutical-grade manufacturing, stability validation, and quality assurance. The company has supported thousands of NAD+ treatments globally and continues to invest in research, manufacturing standards, and international partnerships to advance responsible access to NAD+ therapies.
remedyplace@aiir.agency
AIIR
